Preliminary Results of a Phase I Study of Pharmacological Ascorbate (P-AscH-) with Gemcitabine Chemoradiotherapy in Pancreatic Cancer

被引：1
|
作者：
Wilkes, Justin [1 ]
Allen, Bryan [1 ]
Berg, Daniel J. [1 ]
Wagner, Brett [1 ]
Du, Juan [1 ]
Bodeker, Kellie [1 ]
Ahmann, Logan [1 ]
Vollstedt, Sandy [1 ]
Brown, Heather [1 ]
Alexander, Matthew [1 ]
Cullen, Joseph [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2016年 / 100卷
关键词：
D O I：
10.1016/j.freeradbiomed.2016.10.347
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
306
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [1] Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
    Welsh, J. L.
    Wagner, B. A.
    van't Erve, T. J.
    Zehr, P. S.
    Berg, D. J.
    Halfdanarson, T. R.
    Yee, N. S.
    Bodeker, K. L.
    Du, J.
    Roberts, L. J., II
    Drisko, J.
    Levine, M.
    Buettner, G. R.
    Cullen, J. J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 765 - 775
  • [2] Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial
    J. L. Welsh
    B. A. Wagner
    T. J. van’t Erve
    P. S. Zehr
    D. J. Berg
    T. R. Halfdanarson
    N. S. Yee
    K. L. Bodeker
    J. Du
    L. J. Roberts
    J. Drisko
    M. Levine
    G. R. Buettner
    J. J. Cullen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 765 - 775
  • [3] A phase II trial of pharmacological ascorbate, gemcitabine, and nabpaclitaxel for metastatic pancreatic cancer.
    Kasi, Pashtoon Murtaza
    Bodeker, Kellie
    Berg, Daniel James
    Chandrasekharan, Chandrikha
    Sharif, Saima
    Smith, Brian J.
    Vollstedt, Sandy
    Brown, Heather
    Chandler, Meghan
    Cullen, Joseph J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [4] Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma
    Wilkes, Justin G.
    O'Leary, Brianne R.
    Du, Juan
    Klinger, Adrienne R.
    Sibenaller, Zita A.
    Doskey, Claire M.
    Gibson-Corley, Katherine N.
    Alexander, Matthew S.
    Tsai, Susan
    Buettner, Garry R.
    Cullen, Joseph J.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (1-2) : 37 - 51
  • [5] Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study
    Francois, E.
    Bennouna, J.
    Chamorey, E.
    Etienne-Grimaldi, M. C.
    Renee, N.
    Senellart, H.
    Michel, C.
    Follana, P.
    Mari, V.
    Douillard, J. Y.
    Milano, G.
    CHEMOTHERAPY, 2012, 58 (05) : 371 - 380
  • [6] A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer
    Bodeker, Kellie L.
    Smith, Brian J.
    Berg, Daniel J.
    Chandrasekharan, Chandrikha
    Sharif, Saima
    Fei, Naomi
    Vollstedt, Sandy
    Brown, Heather
    Chandler, Meghan
    Lorack, Amanda
    McMichael, Stacy
    Wulfekuhle, Jared
    Wagner, Brett A.
    Buettner, Garry R.
    Allen, Bryan G.
    Caster, Joseph M.
    Dion, Barbara
    Kamgar, Mandana
    Buatti, John M.
    Cullen, Joseph M.
    REDOX BIOLOGY, 2024, 77
  • [7] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Suguru Yamada
    Tsutomu Fujii
    Yukihiro Yokoyama
    Hiroki Kawashima
    Osamu Maeda
    Kojiro Suzuki
    Tohru Okada
    Eizaburo Ono
    Junpei Yamaguchi
    Nao Takano
    Hideki Takami
    Masamichi Hayashi
    Yukiko Niwa
    Yoshiki Hirooka
    Yoshiyuki Ito
    Shinji Naganawa
    Yuichi Ando
    Masato Nagino
    Hidemi Goto
    Yasuhiro Kodera
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 815 - 821
  • [8] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Yamada, Suguru
    Fujii, Tsutomu
    Yokoyama, Yukihiro
    Kawashima, Hiroki
    Maeda, Osamu
    Suzuki, Kojiro
    Okada, Tohru
    Ono, Eizaburo
    Yamaguchi, Junpei
    Takano, Nao
    Takami, Hideki
    Hayashi, Masamichi
    Niwa, Yukiko
    Hirooka, Yoshiki
    Ito, Yoshiyuki
    Naganawa, Shinji
    Ando, Yuichi
    Nagino, Masato
    Goto, Hidemi
    Kodera, Yasuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (05) : 815 - 821
  • [9] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
    Yamada, Suguru
    Fujii, Tsutomu
    Takano, Nao
    Takami, Hideki
    Suenaga, Masaya
    Niwa, Yukiko
    Hayashi, Masamichi
    Iwata, Naoki
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [10] A phase I study of erlotinib, bevacizumab and gemcitabine in patients with advanced pancreatic cancer
    Gomez-Martin, C.
    Camara, J. C.
    Cortes, H.
    Jara, C.
    Gravalos, C.
    Rubio, B.
    Amador, M. L.
    Hidalgo, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345